1
Eltrombopag for Chemotherapy-induced Thrombocytopenia: a Prospective Single-center One-arm Study
Condition(s):Chemotherapy-induced Thrombocytopenia; EltrombopagLast Updated:October 23, 2020Recruiting
Eltrombopag: 153 Clinical Trials, Page 1 of 16
Hide Studies Not Open or Pending
2
A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia
Condition(s):Solid TumorLast Updated:October 24, 2017Unknown status
3
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
Condition(s):Eltrombopag; Thrombocytopenia; Acute Myeloid LeukemiaLast Updated:October 9, 2018Unknown status
4
Eltrombopag in Children With Idiopathic Aplastic Anemia
Condition(s):EltrombopagLast Updated:July 8, 2020Recruiting
5
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)
Condition(s):Immune ThrombocytopeniaLast Updated:September 1, 2020Recruiting
6
Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation
Condition(s):Poor Graft FunctionLast Updated:February 19, 2018Unknown status
7
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia
Condition(s):ThrombocytopeniaLast Updated:November 4, 2020Recruiting
8
Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)
Condition(s):Immune ThrombocytopeniaLast Updated:September 1, 2020Recruiting
9
Immunomodulation With Eltrombopag in ITP
Condition(s):Primary Immune Thrombocytopenia (ITP)Last Updated:April 2, 2021Not yet recruiting
10
A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
Condition(s):Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell LymphomaLast Updated:February 15, 2016Terminated